Abstract
ABSTRACT: The heme oxygenase inhibitor, tin protoporphyrin, is being studied for the prevention of neonatal jaundice. This potential drug, however, is also a photosensitizer that could cause serious and unknown side effects when administered to newborns. Therefore, we have developed in vitro and in vivo procedures for the screening and further characterization of potentially safe heme oxygenase inhibitors. The ideal inhibitor: 1) contains a biocompatible metal, 2) is not degraded in tissues, 3) is a highly potent inhibitor of heme oxygenase, and 4) does not participate in photochemical reactions. Proto- and mesoporphyrin derivatives with the tin, zinc, manganese, chromium, nickel, and magnesium were screened in vitro for suitability. Chromium protoporphyrin and mesoporphyrin were further studied in vitro and in vivo and were found to meet the ideal criteria. Chromium mesoporphyrin appeared to be the most potent in vitro inhibitor of adult Wistar rat tissue heme oxygenase. Four μ mol of chromium protoporphyrin or chromium mesoporphyrin/kg body weight, administered intraperitoneally to adult male Wistar rats given a heme load through intraperitoneal administration of 30 μ mol heme/kg body weight, caused significant suppression of hemolysis-induced increase in carbon monoxide production to 72 and 44% of control, respectively, 5.5 h after treatment. At t = 6 h, the tissue heme oxygenase activity, measured in vitro, was significantly reduced to 33 and <5% in liver and to 22 and <5% in spleen after the administration of chromium protoporphyrin and mesoporphyrin, respectively, but was not reduced in brain. The results show that there exist effective metalloporphyrin heme oxygenase inhibitors without photosensitizing properties.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verman, H., Ekstrand, B. & Stevenson, D. Selection of Metalloporphyrin Heme Oxygenase Inhibitors Based on Potency and Photoreactivity. Pediatr Res 33, 195–200 (1993). https://doi.org/10.1203/00006450-199302000-00021
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199302000-00021
This article is cited by
-
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Signal Transduction and Targeted Therapy (2023)
-
Effect of light exposure on metalloporphyrin-treated newborn mice
Pediatric Research (2012)
-
In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins
Journal of Perinatology (2011)
-
Selectivity of imidazole–dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms
British Journal of Pharmacology (2006)
-
NICHD Conference on Kernicterus: Research on Prevention of Bilirubin-Induced Brain Injury and Kernicterus: Bench-to-Bedside—Diagnostic Methods and Prevention and Treatment Strategies
Journal of Perinatology (2004)